DK446684A - Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme - Google Patents

Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme Download PDF

Info

Publication number
DK446684A
DK446684A DK446684A DK446684A DK446684A DK 446684 A DK446684 A DK 446684A DK 446684 A DK446684 A DK 446684A DK 446684 A DK446684 A DK 446684A DK 446684 A DK446684 A DK 446684A
Authority
DK
Denmark
Prior art keywords
endotoxine
taxed
organism
pyridine
purified
Prior art date
Application number
DK446684A
Other languages
Danish (da)
English (en)
Other versions
DK446684D0 (da
Inventor
John Leonard Cantrell
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of DK446684D0 publication Critical patent/DK446684D0/da
Publication of DK446684A publication Critical patent/DK446684A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK446684A 1983-09-23 1984-09-19 Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme DK446684A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/535,037 US4663306A (en) 1983-09-23 1983-09-23 Pyridine-soluble extract-refined detoxified endotoxin composition and use

Publications (2)

Publication Number Publication Date
DK446684D0 DK446684D0 (da) 1984-09-19
DK446684A true DK446684A (da) 1985-03-24

Family

ID=24132594

Family Applications (1)

Application Number Title Priority Date Filing Date
DK446684A DK446684A (da) 1983-09-23 1984-09-19 Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme

Country Status (23)

Country Link
US (1) US4663306A (xx)
JP (1) JPS60120817A (xx)
KR (1) KR870000843B1 (xx)
AT (1) AT385659B (xx)
AU (1) AU566234B2 (xx)
BE (1) BE900650A (xx)
CA (1) CA1244765A (xx)
CH (1) CH664897A5 (xx)
DE (1) DE3434766C2 (xx)
DK (1) DK446684A (xx)
ES (1) ES8608872A1 (xx)
FI (1) FI843716L (xx)
FR (1) FR2552326B1 (xx)
GB (1) GB2149301B (xx)
HU (1) HU192585B (xx)
IL (1) IL73034A (xx)
IN (1) IN157240B (xx)
IT (1) IT1179444B (xx)
NL (1) NL8402902A (xx)
NO (1) NO843776L (xx)
NZ (1) NZ209635A (xx)
SE (1) SE8404707L (xx)
ZA (1) ZA847405B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
DE69429521T2 (de) * 1993-08-27 2002-07-18 Vetrepharm, Inc. Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
BE1007823A3 (fr) * 1993-12-10 1995-10-31 Anda Biolog Sa Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer.
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
DE19710255A1 (de) * 1997-03-13 1998-09-17 Henkel Ecolab Gmbh & Co Ohg Verwendung einer Lösung zur Desaktivierung von Endotoxinen
CA2299548C (en) 1997-08-05 2009-12-29 Bioniche Inc. Composition and method for regulating cell proliferation and cell death
US6019985A (en) * 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
KR100628007B1 (ko) 1998-07-16 2006-09-26 이치로 아즈마 세균의 균체성분을 유효성분으로 하는 암면역요법용 제제
EP1238070B1 (en) * 1999-12-13 2007-08-15 Bioniche Life Sciences Inc. Therapeutically useful synthetic oligonucleotides
CA2395493C (en) * 1999-12-28 2010-06-22 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
CA2415399C (en) * 2000-07-11 2011-11-08 Bayer Aktiengesellschaft Use of strains of the parapox ovis virus against organ fibrosis
BR0215643A (pt) * 2002-03-05 2004-12-21 Cell Medicine Inc Adjuvante imunológico de tecido solidificado
WO2004012751A1 (ja) * 2002-08-02 2004-02-12 Sumitomo Pharmaceuticals Company, Limited 細菌細胞壁骨格成分製剤
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
WO2005023277A1 (fr) * 2003-09-05 2005-03-17 Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. Composition a la base de squelettes de parois de cellules de nocardia rouge procede de preparation et son utilisation therapeutique pour traiter l'erosion cervicale
US20080032384A1 (en) * 2004-04-22 2008-02-07 Takehiko Nomura Pharmaceutical Preparation Containing Bacterial Cell Wall Skeleton
US8957047B2 (en) 2013-04-18 2015-02-17 Immune Design Corp. GLA monotherapy for use in cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
BR112016029581B1 (pt) 2014-06-17 2022-05-03 Crown Laboratories, Inc Propionibacterium acnes geneticamente modificada, composição e seus usos
US11504404B2 (en) 2016-02-24 2022-11-22 Crown Laboratories, Inc. Skin probiotic formulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (xx) * 1972-06-20 1973-12-27
FR2269962B1 (xx) * 1974-05-06 1978-02-03 Anvar
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白ｗｅｎａｃ及びその製造法
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1209504A (en) * 1982-06-30 1986-08-12 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism

Also Published As

Publication number Publication date
IT8448894A0 (it) 1984-09-24
GB2149301A (en) 1985-06-12
IL73034A (en) 1988-11-15
IN157240B (xx) 1986-02-15
IT1179444B (it) 1987-09-16
BE900650A (fr) 1985-03-21
NL8402902A (nl) 1985-04-16
FI843716L (fi) 1985-03-24
DE3434766C2 (de) 1987-05-14
ATA302384A (de) 1987-10-15
HUT35521A (en) 1985-07-29
KR870000843B1 (ko) 1987-04-25
NZ209635A (en) 1989-01-27
US4663306A (en) 1987-05-05
FR2552326A1 (fr) 1985-03-29
CH664897A5 (de) 1988-04-15
CA1244765A (en) 1988-11-15
AU566234B2 (en) 1987-10-15
ES8608872A1 (es) 1986-07-16
SE8404707D0 (sv) 1984-09-20
KR850002404A (ko) 1985-05-13
JPS60120817A (ja) 1985-06-28
GB2149301B (en) 1988-06-22
DK446684D0 (da) 1984-09-19
GB8423993D0 (en) 1984-10-31
NO843776L (no) 1985-03-25
DE3434766A1 (de) 1986-04-30
SE8404707L (sv) 1985-03-24
AU3340084A (en) 1985-03-28
ZA847405B (en) 1985-05-29
FR2552326B1 (fr) 1988-05-13
AT385659B (de) 1988-05-10
ES536167A0 (es) 1986-07-16
HU192585B (en) 1987-06-29
JPS6254775B2 (xx) 1987-11-17
FI843716A0 (fi) 1984-09-21

Similar Documents

Publication Publication Date Title
DK446684D0 (da) Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme
NO166518C (no) Stol med vektsavhengig tilbakestillingskraft for rygglenet
DK569784A (da) Farmaceutisk baeremedium med forsinket virkning
IL71967A (en) Drug administration composition
SE8801813D0 (sv) Pharmaceutical composition
IT1209667B (it) Composizione effeverscente adattivita' analgesica.
DK408788A (da) Fremstilling af terapeutiske ringe
FI821240A0 (fi) Med dubbelmod fungerande maetaravlaesningsanordning
DK529885D0 (da) Farmaceutiske kapsler med langvarig frigivelse
DK683987A (da) Topisk farmaceutisk praeparat til anvendelse i form af tape
PH21029A (en) Benzene derivatives, pharmaceutical compositions and method of use thereof
DK49488D0 (da) Anaestesi-praeparat
FI822670A0 (fi) Ergopeptinderivat, foerfaranden foer deras framstaellning, dessa innehaollande farmaceutiska kompositioner och deras anvaendning vid terapeutisk behandling
IT1182061B (it) Derivati di amminofenolo, procedimento per prepararli e composizione farmaceutica che li contiene
IT8519385A0 (it) Composizione farmaceutica
DE3673882D1 (de) Polycarbonatzusammensetzung.
IL77565A (en) Polycyclic salts,their manufacture and pharmaceutical compositions containing them
BR8602887A (pt) Composicao refrataria
BR8602904A (pt) Composicao refrataria
FI853228L (fi) Nya -butyrolaktamer, deras farmaceutiskt aktiva kompositioner, foerfaranden foer deras framstaellning och deras anvaendning som laekemedel.
DK122285D0 (da) Etopsidpraeparat til oral administrering
DK201884A (da) Farmaceutisk praeparat med anti-hypertensiv virkning
DK620989D0 (da) Anvendelse af et prostaglandin af e-typen i kombination med cyclosporin til fremstilling af et farmaceutisk praeparat
IT1181736B (it) Derivati di imidazopiridazina,composizione farmaceutica che li contiene e procedimento per prepararli
BR6500407U (pt) Composicao medicinal

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment